The selection of marmoset monkeys (Callithrix jacchus) in pharmaceutical toxicology

Laboratory Animals

Volumn 35, Issue 2, 2001, Pages 117-130

  Smith, D ^a   Trennery, P ^b   Farningham, D ^b   Klapwijk, J ^b  

^a ASTRAZENECA   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Callithrix jacchus; Ferret; Marmoset; Minipig; Pathology; Toxicology

Indexed keywords

DOG; DRUG METABOLISM; FERRET; MACACA; MARMOSET; NONHUMAN; REVIEW; SPECIES DIFFERENCE; SWINE; TOXICITY TESTING;

ANIMAL WELFARE; ANIMALS; CALLITHRIX; DOGS; DRUG APPROVAL; DRUG EVALUATION, PRECLINICAL; DRUG INDUSTRY; FERRETS; MODELS, ANIMAL; SWINE; SWINE, MINIATURE; TOXICITY TESTS;

ANIMALIA; CALLITHRIX JACCHUS; CANIS FAMILIARIS; MACACA; MARMOSETS; MUSTELA PUTORIUS FURO; RODENTIA; SUS SCROFA;

EID: 0035064882     PISSN: 00236772     EISSN: None     Source Type: Journal    
DOI: 10.1258/0023677011911444     Document Type: Review

References (62)

1. Chronic administration of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine to monkeys: Behavioural, morphological and biochemical correlates
2. RPR107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent comparison with inhibitors of HMG-CoA reductase
3. How to obtain individual urine samples from undisturbed marmoset families
4. The ferret for non-rodent toxicity studies - A pathologists view
5. Induction of liver microsomal P450 in cynomolgus monkeys
6. Comparative aspects of detoxification in mammals
7. A survey of the pathology of marmosets (Callithrix jacchus) derived from a marmoset breeding unit
8. Marmosets: Their use in safety pharmacology and animal models of CNS disorders
9. The animal house: Design, equipment and environmental control
10. Isolation and characterisation of several plasma apolipoproteins of common marmoset monkey
11. The diagnostic usefulness of isocitrate dehydrogenase (ICDH) in the marmoset (Callithrix jacchus)
12. Soman levels in kidney and urine following administration to rat, guinea-pig and marmoset
13. Physical environment and its influence on behaviour in captive common marmosets (Callithrix jacchus)
14. Report on primate supply for biomedical scientific work in the UK
15. Use of subcutaneous vascular access ports in common marmosets (Callithrix jacchus)
16. Non-human primates
17. The neuropathology of trimethyl tin in the marmoset (Callithrix jacchus) hippocampal formation
18. Hepatic effects of ciprofibrate in the marmoset
19. Transfer of various polychlorinated dibenzo-p-dioxins and dibenzofurans PCDDS and PCDFS via placenta and through milk in a marmoset monkey
20. The ferret as a replacement for the dog in toxicity studies
21. Extrahepatic peroxisome proliferation and the extrahepatic effects of peroxisome proliferators
22. Use of ferrets in toxicity testing
23. Conducting developmental toxicity studies using the ferret: Retinoic acid as a positive control
24. Current practice in maintaining marmosets: Results of a UK survey
25. s: Study for expression and molecular cloning of their cDNAs
26. Embryotoxic effects of thalidomide derivatives in the non-human primate Callithrix jacchus
27. The primate as a model for hazard assessment of teratogens in humans. Mechanisms and models in toxicology
28. Four-week repeated inhalation study of HCFC 225ca and HCFC225cb in the common marmoset
29. Screening procedure for assessment of ototoxicity in the common marmoset
30. Systems for collection of urine in the captive common marmoset, Callithrix jacchus
31. Species differences in ciprofibrate induction of hepatic cytochrome P450 4A1 and peroxisome proliferation
32. Blood pressure effects of renin inhibition by human renin antiserum in normotensive marmosets
33. Choice of tests of reproductive toxicity and on immune reactions with recombinant proteins
34. Cross-reactivity of antihuman monoclonal antibodies with cell surface receptors in the common marmoset
35. Thalidomide and the immune system. 4. Down regulation of the CD26 receptor, probably involved in the binding of HW components to T cells in primates
36. Evaluation of the toxicity of indomethacin in a 4-week study by the oral route in the marmoset (Callithrix jacchus)
37. Toxicity of a novel HMGCoA reductase inhibitor in the common marmoset (Callithrix jacchus)
38. Macaque and marmoset monkeys as animal models for the study of birth defects
39. The marmoset as an animal model for teratological research
40. Carcinogenesis by hepatic peroxisome proliferators: Evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans
41. Comparative pharmacokinetics and subacute toxicity of di(2-ethylhexyl) phthalate (DEHP) in rats and marmosets: Extrapolation of effects in rodents to man
42. Use of marmoset in pharmacology and toxicology. The regulatory position
43. A backpack system for long-term osmotic minipump infusions into unrestrained marmoset monkeys
44. Morphological and histochemical effects of 2, 3, 7, 8-tetrachlorodibenzo-p dioxin (TCDD) on marmoset (Callithrix jacchus) testes
45. Long-term interleukin-6 administration stimulates sustained thrombopoiesis and acute-phase protein synthesis in a small primate - The marmoset
46. Marmoset CYP1A2: Primary structure and constitutive expression in livers
47. Measurement of blood pressure and heart rate by telemetry in conscious unrestrained marmosets
48. The use of marmosets (Callithrix jacchus) in teratological and toxicological research
49. Value of non-human primate data
50. The minipig in toxicology
51. Experimental development of the complete marmoset diet
52. The ferret. Mustela putorius furo, as a new species in toxicology
53. Urine collection in the common marmoset (Callithrix jacchus) and its applicability to endocrinological studies
54. A survey of the pathology of marmosets (Callithrix jacchus) under experiment
55. Toxicological studies in primates with three fibrates
56. 1-tetrachlorobiphenyl in the marmoset monkey (Callithrix jacchus)
57. Spontaneous and background pathology in marmosets
58. Introduction to laboratory animal husbandry: Primates
59. Sustained reduction in blood pressure during chronic administration of a renin inhibitor to normotensive marmosets
60. The use of Callithrix jacchus in toxicity studies: Study direction and clinical monitoring